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Background
Alterations in cell proliferation and tissue remodeling are
major hallmarks of cancer. Given that these two physiolo-
gical processes require a significant investment of meta-
bolic resources, we hypothesize that the metabolism of
cancer cells is, in a first approximation, determined by the
magnitude of cell proliferation and tissue remodeling.
Materials and methods
To address this question in further detail we have analyzed
in vitro data characterizing cancer cell lines and gene
expression profiles of human cancers.
Results
We show that the metabolism of cancer cells is strongly
correlated with cell proliferation and tissue remodeling.
Based on in vitro data, cancer cell lines align from an
extreme of highly proliferating cells of relatively small
size to another extreme of slowly proliferating cells with
large size and mesenchymal properties [1]. Similarly, in
human cancers we detect a strong negative correlation
between gene signatures associated with cell proliferation
and tissue remodeling [2]. The stratification of human
cancers based on the cell-proliferation/ tissue-remodeling
signatures results in divergence in the survival plots as
significant as those obtained using current site-specific
classifications. Furthermore, in vitro data suggest that
these different subtypes have a differential sensitivity to
diverse drug classes targeting metabolism [1].
Conclusions
We conclude that human cancers can be subject to a
universal cell-proliferation/tissue-remodeling classifica-
tion independent of their site of origin that can guide
personalized treatment targeting cancer metabolism.
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